The abuse of alcohol, one of the well-liked psychoactive substances, may cause a number of pathological and psychological penalties, together with alcohol use dysfunction (AUD). An impaired capability to cease or management alcohol consumption regardless of opposed well being or social penalties characterize AUD. Whereas AUDs predominantly happen in males, rising proof suggests the existence of distinct cognitive and organic penalties of alcohol dependence in ladies. The molecular and physiological mechanisms taking part in these differential results stay unknown. Transcriptomic know-how permits the detection of the organic mechanisms accountable for such sex-based variations, which helps the following improvement of novel personalised therapeutics to deal with AUD.
We performed a scientific evaluate and meta-analysis of transcriptomics research concerning alcohol dependence in people with illustration from each sexes. For every examine, we processed and analyzed transcriptomic information to acquire a purposeful profile of pathways and organic capabilities after which built-in the ensuing information by meta-analysis to characterize any sex-based transcriptomic variations related to AUD.
International outcomes of the transcriptomic evaluation revealed the affiliation of decreased tissue regeneration, embryo malformations, altered intracellular transport, and elevated charge of RNA and protein substitute with feminine AUD sufferers. In the meantime, our evaluation indicated that elevated inflammatory response and blood stress and a discount in DNA restore capabilities are related to male AUD sufferers. In abstract, our purposeful meta-analysis of transcriptomic research gives proof for differential organic mechanisms of AUD sufferers of differing intercourse.
The sector of artificial biology heralds a brand new period in our relationship with nature, as organisms are engineered to satisfy human targets. However little consideration has been paid to potential cognitive constraints on reasoning about such applied sciences. Throughout 4 research with American adults (N = 649), the current analysis investigates the proposal that essentialist reasoning and ethical purity issues conspire to form danger assessments of engineered organisms. Ethical purity issues however not ethical hurt issues predict ethical wrongness judgments of including a overseas gene to a plant (Research 1, 2 & 4), in addition to assessments of danger (Research 1 and a couple of), and danger of hurt from consuming (Examine 4).
Including a gene from a taxonomically distant organism is taken into account extra morally flawed (Research 2, Three and 4), extra dangerous (Research 2 & 3), and extra dangerous to eat (Examine 4), than including both a gene from an identical organism or a new-to-nature gene. Assessments of the chance of gene unfold comply with a special sample, with the new-to-nature gene thought-about most secure (Examine 4). The findings help the proposal that gene change is reasoned about as essence change that threatens notions of ethical purity, with direct implications for sure kinds of danger perceptions (consuming), however not others (gene unfold).
Modeling a Cognitive Transition on the Origin of Cultural Evolution Utilizing Autocatalytic Networks
Autocatalytic networks have been used to mannequin the emergence of self-organizing construction able to sustaining life and present process organic evolution. Right here, we mannequin the emergence of cognitive construction able to present process cultural evolution. Psychological representations (MRs) of information and experiences play the function of catalytic molecules, and interactions amongst them (e.g., the forging of latest associations) play the function of reactions and end in representational redescription. The method tags MRs with their supply, that’s, whether or not they had been acquired by way of social studying, particular person studying (of pre-existing info), or inventive thought (ensuing within the era of latest info). This makes it doable to mannequin how cognitive construction emerges and to hint lineages of cumulative tradition step-by-step.

We develop a proper illustration of the cultural transition from Oldowan to Acheulean instrument know-how utilizing Reflexively Autocatalytic and Meals set generated (RAF) networks. In contrast to extra primitive Oldowan stone instruments, the Acheulean hand axe required not solely the capability to examine and convey into being one thing that didn’t but exist, however hierarchically structured thought and motion, and the era of latest MRs: the ideas EDGING, THINNING, SHAPING, and a meta-concept, HAND AXE. We present how this constituted a key transition towards the emergence of semantic networks that had been self-organizing, self-sustaining, and autocatalytic, and we focus on how such networks replicated by way of social interplay. The mannequin gives a promising method to unraveling one of many biggest anthropological mysteries: that of why improvement of the Acheulean hand axe was adopted by over one million years of cultural stasis.
Starting of life ethics on the daybreak of a brand new period of genome modifying: are bioethical precepts and fast-evolving biotechnologies irreconcilable?
The superb and virtually unimaginable advances which have unfolded over the previous a long time in biotechnologies (heritable germline modifying particularly) have introduced bioethical points to the forefront, sparking public debate and growing consideration worldwide. Such mind-blowing progress has already resulted in main enchancment and enhancements for people, and holds the potential for much more. Expertise and bioengineering have begun to take over within the life sciences trade.
Man’s capability to genetically engineer the organic world is nothing in need of mind-boggling in its present magnitude, and will even evolve, in a not too distant future, into makes an attempt to fuse man and machine right into a cohesive bioengineered entity; a “tremendous human being”, endowed with enhanced cognitive and bodily capabilities and impervious to illness, could also be not too far down the highway. That won’t come with out caveats, nevertheless.
Mouse Recombinant Purified Noggin-Fc protein, biologically active |
NOGN25-R-25 |
Alpha Diagnostics |
25 ug |
EUR 781.2 |
Purified (CHO cells) Recombinant Human BMP7 protein, Biologically active |
BMP75-R-10 |
Alpha Diagnostics |
10 ug |
EUR 1074 |
Recombinant (E. coli) purified Human Angiogenin protein, biologically active |
ANGN15-R-50 |
Alpha Diagnostics |
50 ug |
EUR 927.6 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-100 |
Alpha Diagnostics |
100 ug |
EUR 562.8 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 1951.2 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically active |
ENST13-R-250 |
Alpha Diagnostics |
250 ug |
EUR 854.4 |
Mouse Recombinant Purified Noggin protein (E. coli), biologically active |
NOGN26-R-20 |
Alpha Diagnostics |
20 ug |
EUR 781.2 |
Mouse Recombinant Purified Noggin protein (E. coli), biologically active |
NOGN26-R-5 |
Alpha Diagnostics |
5 ug |
EUR 343.2 |
Purified (E.Coli) Recombinant Human BMP2 protein, Biologically active, Carrier free |
BMP25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 1074 |
Purified Human Angiostatin (Kringles 1-4) protein (>98%), biologically active |
ANST11-R |
Alpha Diagnostics |
100 ug |
EUR 416.4 |
Recombinant purified human GST-alpha (GST-A1) protein biologically active |
GSTA15-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-alpha (GST-A1) protein biologically active |
GSTA15-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified human GST-mu (GST-M1) protein biologically active |
GSTM25-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-mu (GST-M1) protein biologically active |
GSTM25-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified human GST-pi (GST-P1) protein biologically active |
GSTP35-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-pi (GST-P1) protein biologically active |
GSTP35-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Human Recombinant (E.Coli) Angiostatin Kringles 1-3 purified protein biologically active |
ANKR131-R-250 |
Alpha Diagnostics |
250 ug |
EUR 927.6 |
Human Recombinant (E.Coli) Angiostatin Kringles 1-3 purified protein biologically active |
ANKR131-R-50 |
Alpha Diagnostics |
50 ug |
EUR 270 |
Recombinant purified Human Heme Oxygenase 2 (HO-2) protein (biologically active) |
HO25-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified human GST-alpha 3 (GST A3-3) protein biologically active |
GSTA35-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-alpha 3 (GST A3-3) protein biologically active |
GSTA35-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified human GST-T1-1 (GST T1-1) protein biologically active |
GSTT45-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1000.8 |
Recombinant purified human GST-T1-1 (GST T1-1) protein biologically active |
GSTT45-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Recombinant purified Mouse Endostatin protein (P. Pastoris) biologically active, low endotoxin |
ENST15-R-100 |
Alpha Diagnostics |
100 ug |
EUR 562.8 |
Recombinant purified Mouse Endostatin protein (P. Pastoris) biologically active, low endotoxin |
ENST15-R-250 |
Alpha Diagnostics |
250 ug |
EUR 854.4 |
Recombinant purified Rat Heme Oxygenase 1 (HO-1) protein (biologically active) |
HO15-R-25 |
Alpha Diagnostics |
25 ug |
EUR 416.4 |
Human Calcineurin A-subunit protein biologically active |
CALNA15-R |
Alpha Diagnostics |
1000 U |
EUR 416.4 |
Human Recombinant VEGF121 Protein (Sf9), biologically active |
VEGF24-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF121 Protein (Sf9), biologically active |
VEGF24-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF121 Protein (E.Coli), biologically active |
VEGF25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF121 Protein (E.Coli), biologically active |
VEGF25-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2690.4 |
Human Recombinant VEGF165 Protein (E.Coli), biologically active |
VEGF26-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 11022 |
Human Recombinant VEGF165 Protein (Sf9), biologically active |
VEGF27-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Human Recombinant VEGF165 Protein (HEK), biologically active |
VEGF27-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Human Recombinant VEGF165 Protein (Sf9), biologically active |
VEGF27-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 11022 |
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
TNFA15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 270 |
Human Plasminogen (Plg) Protein (Active) |
20-abx655799 |
Abbexa |
-
EUR 661.20
-
EUR 309.60
-
EUR 1930.80
-
EUR 777.60
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Plasminogen (Plg) Protein (Active) |
20-abx655800 |
Abbexa |
-
EUR 661.20
-
EUR 309.60
-
EUR 1930.80
-
EUR 777.60
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Active Plasminogen (Plg) |
4-APB236Hu01 |
Cloud-Clone |
-
EUR 468.36
-
EUR 248.40
-
EUR 1426.37
-
EUR 555.46
-
EUR 990.91
-
EUR 388.80
-
EUR 3385.92
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Active Plasminogen (Plg) expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Active Plasminogen (Plg) |
4-APB236Hu51 |
Cloud-Clone |
-
EUR 468.36
-
EUR 248.40
-
EUR 1426.37
-
EUR 555.46
-
EUR 990.91
-
EUR 388.80
-
EUR 3385.92
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Plasminogen expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Active Plasminogen (Plg) |
4-APB236Ra01 |
Cloud-Clone |
-
EUR 872.64
-
EUR 357.60
-
EUR 2942.40
-
EUR 1060.80
-
EUR 2001.60
-
EUR 660.00
-
EUR 7176.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat Plasminogen expressed in: E.coli |
Purified Recombinant Human BMP-13 (CDMP-2/GDF-6), Biologically active, Carrier free |
BMP135-R-10 |
Alpha Diagnostics |
10 ug |
EUR 489.6 |
Purified Recombinant Human BMP-13 (CDMP-2/GDF-6), Biologically active, Carrier free |
BMP135-R-50 |
Alpha Diagnostics |
50 ug |
EUR 1074 |
Purified Recombinant Human BMP-14 (CDMP-1/GDF-5), Biologically active, Carrier free |
BMP145-R-10 |
Alpha Diagnostics |
10 ug |
EUR 489.6 |
Purified Recombinant Human BMP-14 (CDMP-1/GDF-5), Biologically active, Carrier free |
BMP145-R-50 |
Alpha Diagnostics |
50 ug |
EUR 1074 |
Human Pancreatic Lipase (partially pure) biologically active |
PLIP15-N |
Alpha Diagnostics |
10 U |
EUR 343.2 |
Recombinant (E.Coli) purified rat Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
TNFA25-R-5 |
Alpha Diagnostics |
5 ug |
EUR 270 |
Recombinant (E.Coli) purified mouse Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
TNFA35-R-5 |
Alpha Diagnostics |
5 ug |
EUR 270 |
Recombinant (E.Coli) purified porcine Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
TNFA36-R-5 |
Alpha Diagnostics |
5 ug |
EUR 270 |
Rat Plasminogen (Plg) Protein (Active) |
20-abx651431 |
Abbexa |
-
EUR 1195.20
-
EUR 427.20
-
EUR 3934.80
-
EUR 1446.00
-
EUR 828.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Purified Diphtheria Toxin protein (active) |
DTOX18-N-250 |
Alpha Diagnostics |
250 ug |
EUR 489.6 |
Human Recombinant EG-VEGF Protein (84aa, E. Coli), biologically active |
VEGF36-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2389.2 |
Human Recombinant EG-VEGF Protein (84aa, E. coli), biologically active |
VEGF36-R-20 |
Alpha Diagnostics |
20 ug |
EUR 927.6 |
Human Recombinant EG-VEGF Protein (84aa, E. coli), biologically active |
VEGF36-R-5 |
Alpha Diagnostics |
5 ug |
EUR 388.8 |
Recombinant purified, human NFkB-p65 protein, active |
NFKB651-R-5 |
Alpha Diagnostics |
5 ug |
EUR 781.2 |
Purified, recombinant Human TACE control protein (active) |
TACE15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 854.4 |
Lipase, Human Pancreas (biologically active) antigen grade (.95% pure) |
PLIP15-N-10 |
Alpha Diagnostics |
10 ug |
EUR 343.2 |
Rat Recombinant VEGF152 (VEGF-C) Protein (Sf9), biologically active |
VEGF31-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Rat Recombinant VEGF129 (VEGF-C) Protein (Sf9), biologically active |
VEGF32-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Rat Recombinant VEGF129 (VEGF-C) Protein (Sf9), biologically active |
VEGF32-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2910 |
Rat Recombinant VEGF164 (VEGF-A) Protein (E.Coli), biologically active |
VEGF33-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Rat Recombinant VEGF164 (VEGF-A) Protein (E.Coli), biologically active |
VEGF33-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2973.6 |
Mouse Recombinant VEGF164 (VEGF-A) Protein (Sf9), biologically active |
VEGF34-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Mouse Recombinant VEGF164 (VEGF-A) Protein (Sf9), biologically active |
VEGF34-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2973.6 |
Mouse Recombinant VEGF165 (VEGF-A) Protein (E.Coli), biologically active |
VEGF35-R-10 |
Alpha Diagnostics |
10 ug |
EUR 534 |
Mouse Recombinant VEGF165 (VEGF-A) Protein (E.Coli), biologically active |
VEGF35-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2690.4 |
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha Variant (TNF-alpha variant, 151-aa), biologically active |
TNFA16-R-10 |
Alpha Diagnostics |
10 ug |
EUR 270 |
Active Plasminogen Activator, Tissue (tPA) |
4-APA525Mu01 |
Cloud-Clone |
-
EUR 1025.32
-
EUR 398.40
-
EUR 3514.94
-
EUR 1251.65
-
EUR 2383.30
-
EUR 762.00
-
EUR 8607.36
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Plasminogen Activator, Tissue expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Human Plasminogen Activator Inhibitor 2 (PAI2) Protein (Active) |
20-abx655801 |
Abbexa |
-
EUR 1296.00
-
EUR 477.60
-
EUR 4318.80
-
EUR 1579.20
-
EUR 895.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Recombinant (E. coli), purified, Mouse beta-Defensin 2 (BD-2/mBD-2) full length protein, biologically active |
MBD25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 548.4 |
Purified Human Plasminogen protein W. Blot Positive control |
PLMN11-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Human Recombinant Transforming Growth Factor-alpha (TGF-alpha), biologically active |
TGFA15-R-100 |
Alpha Diagnostics |
100 ug |
EUR 634.8 |
Human Recombinant Transforming Growth Factor-alpha (TGF-alpha), biologically active |
TGFA15-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 4225.2 |
Human Recombinant Transforming Growth Factor-alpha (TGF-alpha), biologically active |
TGFA15-R-20 |
Alpha Diagnostics |
20 ug |
EUR 270 |
Recombinant (E. coli), purified, Human beta-Defensin 4 (BD-4/hBD-4) full length protein (50 aa), biologically active |
HBD45-R-20 |
Alpha Diagnostics |
20 ug |
EUR 708 |
Recombinant (E. coli), purified, Human beta-Defensin 4 (BD-4/hBD-4) full length protein (50 aa), biologically active |
HBD45-R-5 |
Alpha Diagnostics |
5 ug |
EUR 343.2 |
Recombinant (E.Coli), purified, Human beta-Defensin 3 (BD-3/hBD-3, full length peptide (45 aa), biologically active |
HBD37-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant (E.Coli), purified, Human beta-Defensin 3 (BD-3/hBD-3, full length peptide (45 aa), biologically active |
HBD37-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2617.2 |
Recombinant (E.Coli), purified, Human beta-Defensin 3 (BD-3/hBD-3, full length peptide (45 aa), biologically active |
HBD37-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 7221.6 |
Recombinant purified human Akt-1/PKB-alpha protein (active) |
AKT15-R-15 |
Alpha Diagnostics |
15 ug |
EUR 1074 |
Recombinant purified, human Akt-2/PKB-beta protein, active |
AKT25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant purified, human Akt-3/PKB-gamma protein, active |
AKT35-R-5 |
Alpha Diagnostics |
5 ug |
EUR 416.4 |
Recombinant (E. coli), purified, Human beta-Defensin 1 (BD-1/hBD-1) full length peptide (36 aa), biologically active |
HBD17-R-10 |
Alpha Diagnostics |
10 ug |
EUR 460.8 |
Recombinant (E. coli), purified, Human beta-Defensin 1 (BD-1/hBD-1) full length peptide (36 aa), biologically active |
HBD17-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2324.4 |
Recombinant (E. coli), purified, Human beta-Defensin 1 (BD-1/hBD-1) full length peptide (36 aa), biologically active |
HBD17-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 6637.2 |
Recombinant (E. coli), purified, Human beta-Defensin 2 (BD-2/hBD-2) full length peptide (41 aa), biologically active |
HBD25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant (E. coli), purified, Human beta-Defensin 2 (BD-2/hBD-2) full length peptide (41 aa), biologically active |
HBD25-R-100 |
Alpha Diagnostics |
100 ug |
EUR 2617.2 |
Recombinant (E. coli), purified, Human beta-Defensin 2 (BD-2/hBD-2) full length peptide (41 aa), biologically active |
HBD25-R-1000 |
Alpha Diagnostics |
1000 ug |
EUR 7221.6 |
Purified Human Placenta Dipeptidyl Peptidase IV (DPP4), active |
DPP48-N-1 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant (E. coli) purified Firefly Luciferase protein, active |
LUCF15-R |
Alpha Diagnostics |
250 ug |
EUR 336 |
Recombinant (E. coli) human placenta growth factor-1 (PLGF-1) Protein (>97%), biologically active |
PLGF15-R-25 |
Alpha Diagnostics |
25 ug |
EUR 634.8 |
Recombinant (E. coli) human placenta growth factor-1 (PLGF-1) Protein (>97%), biologically active |
PLGF15-R-5 |
Alpha Diagnostics |
5 ug |
EUR 270 |
Recombinant (plant) Human Apotransferrin, Tissue Culture Grade (animal free, biologically active, >95% pure |
TF27-N-100 |
Alpha Diagnostics |
100 mg |
EUR 270 |
Recombinant (plant) Human Apotransferrin, Tissue Culture Grade (animal free, biologically active, >95% pure |
TF27-N-1000 |
Alpha Diagnostics |
100 mg |
EUR 781.2 |
Recombinant, purified, Human O6-methylguanine-DNA-Methyl transferase (MGMT) protein (active) |
MGMT15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 781.2 |
Recombinant, purified, Human O6-methylguanine-DNA-Methyl transferase (MGMT) protein (active) |
MGMT15-R-5 |
Alpha Diagnostics |
5 ug |
EUR 489.6 |
Human recombinant purified matrilysin/MMP7 (matrix metalloproteinase 7) biolgoically active |
MMP71-R |
Alpha Diagnostics |
25 ug |
EUR 315.6 |
Recombinant purified, human Interleukin-1 alpha (IL-1 alpha), active |
IL1A15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Human Plasminogen Protein |
abx060920-1mg |
Abbexa |
1 mg |
EUR 460.8 |
|
Recombinant purified (E. coli, >80%, GST-tag) human NFkB-p50 protein, active |
NFKB502-R-5 |
Alpha Diagnostics |
5 ug |
EUR 489.6 |
Recombinant (HEK) Purified human Transferrin receptor (TfR1/CD71) protein (his-tag), active |
TFR19-R-25 |
Alpha Diagnostics |
25 ug |
EUR 343.2 |
Recombinant (E.Coli) purified, human Protein Kinase Akt1/PKB alpha (PRKBA/PKB) protein, active |
PAKT18-R-5 |
Alpha Diagnostics |
5 ug |
EUR 634.8 |
Recombinant purified human IKKB-beta (Sf9; GST-His-IKK-B), active |
IKKB35-R-5 |
Alpha Diagnostics |
5 ug |
EUR 489.6 |
Recombinant (HEK) Human VEGFR1/FLT1 Protein (1-328aa-IgG1-Fc, >95%, ~67 kda, low endotoxin), biologically active |
VEGFR15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant purified human Akt-1/PKB-alpha protein (PHD deletion 1-116 active) |
AKT16-R |
Alpha Diagnostics |
1 U |
EUR 562.8 |
Recombinant (E.coli) purified human AKT1(Akt-1/PKB-alpha/RAC-alpha) protein, active |
AKT17-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Recombinant (E.coli) purified Human Granulocyte Colony Stimulating Factor (GCSF, G-CSF) protein, active |
GCSF16-R |
Alpha Diagnostics |
10 ug |
EUR 460.8 |
Human Plasminogen |
STA-239 |
Cell Biolabs |
100 µg |
EUR 540 |
Description: - Human Plasminogen protein. 100 µg.
- Provided at a concentration of 1.0 mg/mL
|
Plasminogen protein |
30-AP27 |
Fitzgerald |
1 mg |
EUR 352.8 |
Description: Purified native Human Plasminogen protein |
Human SOD Protein (Active) |
20-abx060221 |
Abbexa |
-
EUR 376.80
-
EUR 878.40
-
EUR 1554.00
|
|
|
Active Human HSP70 Protein |
SPR-103A |
Stressmarq |
0.05 mg |
EUR 360 |
|
Description: His tagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP70 Protein |
SPR-103B |
Stressmarq |
0.1 mg |
EUR 465.6 |
|
Description: His tagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP70 Protein |
SPR-103C |
Stressmarq |
2x0.1 mg |
EUR 802.8 |
|
Description: His tagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP60 Protein |
SPR-104A |
Stressmarq |
0.05 mg |
EUR 277.2 |
|
Description: His tagged recombinant human HSP60 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP60 Protein |
SPR-104B |
Stressmarq |
0.1 mg |
EUR 464.4 |
|
Description: His tagged recombinant human HSP60 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP60 Protein |
SPR-104C |
Stressmarq |
2x0.1 mg |
EUR 681.6 |
|
Description: His tagged recombinant human HSP60 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSC70 Protein |
SPR-106A |
Stressmarq |
0.05 mg |
EUR 283.2 |
|
Description: His tagged recombinant human HSC70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSC70 Protein |
SPR-106B |
Stressmarq |
0.1 mg |
EUR 372 |
|
Description: His tagged recombinant human HSC70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSC70 Protein |
SPR-106C |
Stressmarq |
2x0.1 mg |
EUR 645.6 |
|
Description: His tagged recombinant human HSC70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP70 Protein |
SPR-108A |
Stressmarq |
0.05 mg |
EUR 360 |
|
Description: Untagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP70 Protein |
SPR-108B |
Stressmarq |
0.1 mg |
EUR 465.6 |
|
Description: Untagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP70 Protein |
SPR-108C |
Stressmarq |
2x0.1 mg |
EUR 802.8 |
|
Description: Untagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP70 Protein |
SPR-115A |
Stressmarq |
0.05 mg |
EUR 415.2 |
|
Description: His tagged recombinant human HSP70 Protein expressed in Baculovirus/Hi5 cells for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP70 Protein |
SPR-115B |
Stressmarq |
0.1 mg |
EUR 572.4 |
|
Description: His tagged recombinant human HSP70 Protein expressed in Baculovirus/Hi5 cells for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Active Human HSP70 Protein |
SPR-115C |
Stressmarq |
2x0.1 mg |
EUR 975.6 |
|
Description: His tagged recombinant human HSP70 Protein expressed in Baculovirus/Hi5 cells for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active). |
Human Plasminogen (Plg) Protein |
20-abx068558 |
Abbexa |
-
EUR 427.20
-
EUR 260.40
-
EUR 1161.60
-
EUR 526.80
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Plasminogen (Plg) Protein |
20-abx068560 |
Abbexa |
-
EUR 427.20
-
EUR 260.40
-
EUR 1161.60
-
EUR 526.80
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Plasminogen (Plg) Protein |
20-abx651557 |
Abbexa |
-
EUR 944.40
-
EUR 360.00
-
EUR 2983.20
-
EUR 1128.00
-
EUR 661.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Recombinant (HEK) Human VEGFR2/Kdr/FLK1 Protein (1-764aa-IgG-Fc, >95%, ~160 kda, low endotoxin), biologically active |
VEGFR25-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
Active Human Caspases Group I, Active Human |
K241-3-25 |
Biovision |
each |
EUR 444 |
Recombinant purified human IKB-alpha (E., coli; GST-tag; IKB-alpha), active |
IKBA16-R-10 |
Alpha Diagnostics |
10 ug |
EUR 343.2 |
Recombinant purified Rat brain Nitric Oxide Synthase (bNOS/NOS-1) protein, active |
bNOS14-R-10 |
Alpha Diagnostics |
5 U |
EUR 315.6 |
Recombinant purified Human Klotho protein (NS0 cells, His-tag; Alpha form; EC domain), active |
KL16-R |
Alpha Diagnostics |
5 ug |
EUR 343.2 |
Recombinant purified human IKB-alpha (E., coli; His-tag; 1-317 aa), active |
IKBA15-R-5 |
Alpha Diagnostics |
5 ug |
EUR 343.2 |
Recombinant (E.coli) purified Mouse Granulocyte Colony Stimulating Factor (GCSF, G-CSF) protein, active |
GCSF15-R |
Alpha Diagnostics |
10 ug |
EUR 460.8 |
TET1 Protein (Active) |
E12002-1 |
EpiGentek |
10 ul |
EUR 225.5 |
Active GST Protein |
1243-1 |
Biovision |
each |
EUR 210 |
Recombinnat purified Human Plasminogen Activator Inhibitor 1 (PAI-1) protein (his-tag) control for ELISA |
PAI21-R-25 |
Alpha Diagnostics |
25 ug |
EUR 343.2 |
Human Adenosylhomocysteinase (AHCY) Protein (Active) |
20-abx655555 |
Abbexa |
-
EUR 1362.00
-
EUR 493.20
-
EUR 4536.00
-
EUR 1646.40
-
EUR 927.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Amphiregulin (AREG) Protein (Active) |
20-abx655557 |
Abbexa |
-
EUR 878.40
-
EUR 343.20
-
EUR 2766.00
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Betacellulin (bTC) Protein (Active) |
20-abx655563 |
Abbexa |
-
EUR 1228.80
-
EUR 427.20
-
EUR 4051.20
-
EUR 1479.60
-
EUR 844.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Calreticulin (CRT) Protein (Active) |
20-abx655571 |
Abbexa |
-
EUR 1279.20
-
EUR 477.60
-
EUR 4236.00
-
EUR 1545.60
-
EUR 878.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Endostatin (COL18A1) Protein (Active) |
20-abx655607 |
Abbexa |
-
EUR 1095.60
-
EUR 393.60
-
EUR 3567.60
-
EUR 1328.40
-
EUR 760.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Epigen (EPG) Protein (Active) |
20-abx655610 |
Abbexa |
-
EUR 1095.60
-
EUR 393.60
-
EUR 3567.60
-
EUR 1328.40
-
EUR 760.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Erythropoietin (EPO) Protein (Active) |
20-abx655612 |
Abbexa |
-
EUR 1178.40
-
EUR 410.40
-
EUR 3850.80
-
EUR 1412.40
-
EUR 811.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Hemojuvelin (HJV) Protein (Active) |
20-abx655665 |
Abbexa |
-
EUR 978.00
-
EUR 376.80
-
EUR 3082.80
-
EUR 1161.60
-
EUR 678.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Hepcidin (Hepc) Protein (Active) |
20-abx655669 |
Abbexa |
-
EUR 760.80
-
EUR 326.40
-
EUR 2314.80
-
EUR 910.80
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Lymphotactin (Lptn) Protein (Active) |
20-abx655748 |
Abbexa |
-
EUR 1362.00
-
EUR 493.20
-
EUR 4569.60
-
EUR 1663.20
-
EUR 927.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Midkine (MK) Protein (Active) |
20-abx655772 |
Abbexa |
-
EUR 1412.40
-
EUR 510.00
-
EUR 4736.40
-
EUR 1713.60
-
EUR 961.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Myostatin (MSTN) Protein (Active) |
20-abx655781 |
Abbexa |
-
EUR 1312.80
-
EUR 477.60
-
EUR 4335.60
-
EUR 1579.20
-
EUR 895.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Nephronectin (NPNT) Protein (Active) |
20-abx655783 |
Abbexa |
-
EUR 1312.80
-
EUR 477.60
-
EUR 4335.60
-
EUR 1579.20
-
EUR 895.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Neuroserpin (NSP) Protein (Active) |
20-abx655786 |
Abbexa |
-
EUR 1195.20
-
EUR 427.20
-
EUR 3951.60
-
EUR 1446.00
-
EUR 828.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Noggin (NOG) Protein (Active) |
20-abx655789 |
Abbexa |
-
EUR 927.60
-
EUR 360.00
-
EUR 2899.20
-
EUR 1095.60
-
EUR 644.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Osteonectin (ON) Protein (Active) |
20-abx655792 |
Abbexa |
-
EUR 844.80
-
EUR 343.20
-
EUR 2598.00
-
EUR 994.80
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Osteoprotegerin (OPG) Protein (Active) |
20-abx655793 |
Abbexa |
-
EUR 1028.40
-
EUR 376.80
-
EUR 3283.20
-
EUR 1228.80
-
EUR 710.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Persephin (PSPN) Protein (Active) |
20-abx655797 |
Abbexa |
-
EUR 1178.40
-
EUR 410.40
-
EUR 3850.80
-
EUR 1412.40
-
EUR 811.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Pleiotrophin (PTN) Protein (Active) |
20-abx655808 |
Abbexa |
-
EUR 1095.60
-
EUR 393.60
-
EUR 3567.60
-
EUR 1328.40
-
EUR 760.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Resistin (RETN) Protein (Active) |
20-abx655820 |
Abbexa |
-
EUR 1144.80
-
EUR 410.40
-
EUR 3717.60
-
EUR 1378.80
-
EUR 794.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Heparanase (HPA) Protein (Active) |
20-abx655871 |
Abbexa |
-
EUR 1095.60
-
EUR 393.60
-
EUR 3534.00
-
EUR 1312.80
-
EUR 760.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Arginase (ARG) Protein (Active) |
20-abx651297 |
Abbexa |
-
EUR 1178.40
-
EUR 410.40
-
EUR 3850.80
-
EUR 1412.40
-
EUR 811.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Fibronectin (FN) Protein (Active) |
20-abx651335 |
Abbexa |
-
EUR 927.60
-
EUR 360.00
-
EUR 2899.20
-
EUR 1095.60
-
EUR 644.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
The truth is, scientific developments at such an accelerated tempo have already negatively affected our cultural, moral, and authorized values and our capability to harness the alternatives and face the risks posed by such developments. As a matter of reality, science appears to persistently outpace public morals, ethics and policymaking, which requires a excessive diploma of warning and customary solutions.